We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

301358:SZSEHunan Yuneng New Energy Battery Material Co., Ltd. Class A Analysis

Data as of 2026-03-12 - not real-time

CN¥76.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading at CNY 76.88, comfortably above its 20‑day SMA (66.90), 50‑day SMA (65.57) and 200‑day SMA (50.70), with a bullish MACD histogram (+0.82) and an RSI of 71 indicating strong momentum but potential overbought conditions. It sits just below the calculated resistance of CNY 77.17 and above the support at CNY 59.61, suggesting limited upside in the immediate term.
Fundamental outlook: Revenue has surged 74% year‑over‑year, yet gross margin is only 7.8% and operating cash flow is negative (‑2.14 B CNY). The trailing P/E of 78.4 dwarfs the industry average of 30, while debt‑to‑equity stands at a lofty 89.6, raising concerns about balance‑sheet strength. Dividend yield is modest at 0.22% with a payout ratio of 16%, but cash‑flow constraints cast doubt on sustainability. Risk & valuation: Volatility is high (48% 30‑day) despite a near‑zero beta, and the “Extreme Greed” sentiment index (78.16) reflects market euphoria. Overall, the stock appears overvalued with a growth‑focused profile, but faces significant financial and sector‑specific risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above key moving averages
  • Proximity to resistance at CNY 77.17
  • High RSI indicating possible short‑term pullback

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Robust 74% revenue growth
  • Elevated P/E relative to industry peers
  • High debt load and negative operating cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong tailwinds in EV battery demand
  • Rapid top‑line growth despite margin pressure
  • Potential for balance‑sheet improvement as cash generation improves

Key Metrics & Analysis

Financial Health

Revenue Growth74.00%
Profit Margin2.50%
P/E Ratio78.4
ROE6.20%
ROA2.11%
Debt/Equity89.56
P/B Ratio4.8
Op. Cash FlowCN¥-2135809152
Free Cash FlowCN¥-1153909504
Industry P/E30.0

Technical Analysis

TrendBullish
RSI71.2
SupportCN¥59.61
ResistanceCN¥77.17
MA 20CN¥66.90
MA 50CN¥65.57
MA 200CN¥50.70
MACDBullish
VolumeStable
Fear & Greed Index78.16

Valuation

Target PriceCN¥80.42
Upside/Downside4.60%
GradeOvervalued
TypeGrowth
Dividend Yield0.22%

Risk Assessment

Beta-0.03
Volatility48.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.